48
Participants
Start Date
June 9, 2023
Primary Completion Date
February 1, 2024
Study Completion Date
February 1, 2024
ViXe Xombination
Combination of Xeomin and the ultrasound based delivery system (Vibe) for intravesical administration of the drug in a minimally invasive procedure
Placebo + Sham
Placebo identical in package and appearance to Xeomin together with all steps of Vibe device preparation and activation, but without the actual operation of the ultrasound energy
CHUC, Coimbra
HSOG, Guimarães
CHLN, Lisbon
CHUSJ, Porto
Hospital Lusíadas, Porto
Hospital Prelada, Porto
Hospital Luz Setúbal, Setúbal
CHVNG, Vila Nova de Gaia
Collaborators (1)
Blueclinical, Ltd.
OTHER
Vensica Therapeutics Ltd.
INDUSTRY